Abstract:SUMMARY: Esophageal cancer is one of the most aggressive gastrointestinal cancers. Invasion and metastasis are the main causes of poor prognosis of esophageal cancer. SPRY2 has been reported to exert promoting effects in human cancers, which controls signal pathways including PI3K/AKT and MAPKs. However, the expression of SPRY2 in esophageal squamous cell carcinoma (ESCC) and its underlying mechanism remain unclear. In the present study, we aimed to investigate the detailed role of SPRY2 in the regulation of cell proliferation, invasion and ERK/AKT signaling pathway in ESCC. It was identified that the expression level of SPRY2 in ESCC was remarkably decreased compared with normal tissues, and it was related to clinicopathologic features and prognosis ESCC patients. The upregulation of SPRY2 expression notably inhibited the proliferation, migration and invasion of Eca-109 cells. In addition, the activity of ERK /AKT signaling was also suppressed by the SPRY2 upregulation in Eca-109 cells. Our study suggests that overexpression of SPRY2 suppress cancer cell proliferation and invasion of by through suppression of the ERK/AKT signaling pathways in ESCC. Therefore, SPRY2 may be a promising prognostic marker and therapeutic target for ESCC. RESUMEN: El cncer de esfago es uno de los cnceres gastrointestinales ms agresivos. La invasin y la metstasis son las principales causas de mal pronstico del cncer de esfago. Se ha informado que SPRY2 ejerce efectos promotores en los cnceres humanos, que controla las vas de seales, incluidas PI3K/AKT y MAPK. Sin embargo, la expresin de SPRY2 en el carcinoma de clulas escamosas de esfago (ESCC) y su mecanismo subyacente an no estn claros. En el presente estudio, nuestro objetivo fue investigar el papel detallado de SPRY2 en la regulacin de la proliferacin celular, la invasin y la va de sealizacin ERK/AKT en ESCC. Se identific que el nivel de expresin de SPRY2 en ESCC estaba notablemente disminuido en comparacin con los tejidos normales, y estaba relacionado con las caractersticas clnico-patolgicas y el pronstico de los pacientes con ESCC. La regulacin positiva de la expresin de SPRY2 inhibi notablemente la proliferacin, migracin e invasin de clulas Eca-109. Adems, la actividad de la sealizacin de ERK/AKT tambin fue suprimida por la regulacin positiva de SPRY2 en las clulas Eca-109. Nuestro estudio sugiere que la sobreexpresin de SPRY2 suprime la proliferacin y la invasin de clulas cancerosas mediante la supresin de las vas de sealizacin ERK/AKT en ESCC. Por lo tanto, SPRY2 puede ser un marcador de pronstico prometedor y un objetivo teraputico para la ESCC.

Overexpression SPRY2 Suppresses Esophageal Squamous Cell Carcinoma Progression Via Inactivation of ERK/AKT Signaling

COL8A1 Regulates Esophageal Squamous Carcinoma Proliferation and Invasion Through PI3K/AKT Pathway.

Long noncoding RNA SPRY4-IT1 promotes esophageal squamous cell carcinoma cell proliferation, invasion, and epithelial-mesenchymal transition

Sprouty2 Correlates with Favorable Prognosis of Gastric Adenocarcinoma Via Suppressing FGFR2-induced ERK Phosphorylation and Cancer Progression

Exogenous Expression of Esophagin/SPRR3 Attenuates the Tumorigenicity of Esophageal Squamous Cell Carcinoma Cells Via Promoting Apoptosis

Overexpression of Cancer Upregulated Gene 2 (CUG2) Decreases Spry2 Through c-Cbl, Leading to Activation of EGFR and β-Catenin Signaling

Inhibiting the expression of spindle appendix cooled coil protein 1 can suppress tumor cell growth and metastasis and is associated with cancer immune cells in esophageal squamous cell carcinoma

MiR-92a-2-5p suppresses esophageal squamous cell carcinoma cell proliferation and invasion by targeting PRDX2

S1PR1 Promotes Proliferation and Inhibits Apoptosis of Esophageal Squamous Cell Carcinoma Through Activating STAT3 Pathway

Dysregulation of CXCL14 promotes malignant phenotypes of esophageal squamous carcinoma cells via regulating SRC and EGFR signaling

Tumor fibroblast-derived FGF2 regulates expression of SPRY1 in esophageal tumor-infiltrating T cells and plays a role in T cell exhaustion

EZH2-mediated Epigenetic Suppression of Long Noncoding RNA SPRY4-IT1 Promote S NSCLC Cell Proliferation and Metastasis by Affecting the Epithelial–mesenchymal Transition

SLC35E2 Promoter Mutation As a Prognostic Marker of Esophageal Squamous Cell Carcinoma.

Lower Expression of SPRY4 Predicts a Poor Prognosis and Regulates Cell Proliferation in Colorectal Cancer.

H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma

Suppression of Anoikis by SKP 2 Amplification and Overexpression Promotes Metastasis of Esophageal Squamous Cell Carcinoma

PSCA acts as a tumor suppressor by facilitating the nuclear translocation of RB1CC1 in esophageal squamous cell carcinoma

Upregulated long non-coding RNA SBF2-AS1 promotes proliferation in esophageal squamous cell carcinoma.

Loss of SPRY2 contributes to cancer-associated fibroblasts activation and promotes breast cancer development

Let-7c-5p Inhibits Cell Proliferation and Migration and Promotes Apoptosis via the CTHRC1/AKT/ERK Pathway in Esophageal Squamous Cell Carcinoma

Effect of H3K27 Acetylation Activated-Long Noncoding RNA CCAT1 on Cell Proliferation and Migration by Regulating SPRY4 and HOXB13 Expression in Esophageal Squamous Carcinoma Cell.